Trinity Biotech (TRIB) Current Leases (2016 - 2025)

Trinity Biotech's Current Leases history runs 10 years deep, the most recent figure standing at $2.6 million for Q4 2025.

• In Q4 2025, Current Leases rose 13.26% year-over-year to $2.6 million; the TTM figure through Dec 2025 stood at $2.6 million (up 13.26% YoY), while the FY2025 annual figure was $2.6 million, up 13.26% from the prior year.
• Current Leases came in at $2.6 million for Q4 2025 at Trinity Biotech, up from $2.3 million in the prior quarter.
• In the past five years, Current Leases ranged from a high of $2.6 million in Q4 2025 to a low of $1.7 million in Q4 2022.
• A 5-year average of $2.0 million and a median of $2.0 million in 2021 frame the typical range for Current Leases.
• Across the five-year window, Current Leases retreated 15.35% in 2022 and surged 34.89% in 2024, its largest moves.
• Trinity Biotech's Current Leases stood at $2.0 million in 2021, then declined by 15.35% to $1.7 million in 2022, then rose by 1.07% to $1.7 million in 2023, then surged by 34.89% to $2.3 million in 2024, then advanced by 13.26% to $2.6 million in 2025.
• According to Business Quant data, Current Leases over the past three periods registered $2.6 million, $2.3 million, and $1.7 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison